相似文献
1
The mycobacterial cell envelope-lipids.
Cold Spring Harb Perspect Med. 2014 Aug 7;4(10):a021105. doi: 10.1101/cshperspect.a021105.
2
The binding of mycolic acids to galectin-3: a novel interaction between a host soluble lectin and trafficking mycobacterial lipids?
FEBS Lett. 2005 Dec 19;579(30):6749-55. doi: 10.1016/j.febslet.2005.11.005. Epub 2005 Nov 21.
3
The methyl-branched fortifications of Mycobacterium tuberculosis.
Chem Biol. 2002 May;9(5):545-53. doi: 10.1016/s1074-5521(02)00142-4.
4
Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis.
ScientificWorldJournal. 2008 Jul 31;8:720-51. doi: 10.1100/tsw.2008.99.
5
The cell envelope glycoconjugates of Mycobacterium tuberculosis.
Crit Rev Biochem Mol Biol. 2014 Sep-Oct;49(5):361-99. doi: 10.3109/10409238.2014.925420. Epub 2014 Jun 10.
6
Some observations of mycobacterial acid-fastness.
Am Rev Respir Dis. 1978 Jul;118(1):151-4. doi: 10.1164/arrd.1978.118.1.151.
7
Potential Drug Targets in Mycobacterial Cell Wall: Non-Lipid Perspective.
Curr Drug Discov Technol. 2020;17(2):147-153. doi: 10.2174/1570163815666180605113609.
8
Of mice, men, and elephants: Mycobacterium tuberculosis cell envelope lipids and pathogenesis.
J Clin Invest. 2006 Jun;116(6):1475-8. doi: 10.1172/JCI28734.
9
Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis.
Tuberculosis (Edinb). 2011 May;91(3):187-95. doi: 10.1016/j.tube.2011.01.002. Epub 2011 Feb 16.
10
Down-regulation of PE11, a cell wall associated esterase, enhances the biofilm growth of Mycobacterium tuberculosis and reduces cell wall virulence lipid levels.
Microbiology (Reading). 2017 Jan;163(1):52-61. doi: 10.1099/mic.0.000417.
引用本文的文献
1
Conserved mycobacterial sRNA B11 regulates lipooligosaccharide synthesis at posttranscriptional level in .
mLife. 2025 Aug 25;4(4):447-460. doi: 10.1002/mlf2.70025. eCollection 2025 Aug.
2
Mycobacterium tuberculosis biology, pathogenicity and interaction with the host.
Nat Rev Microbiol. 2025 Jun 30. doi: 10.1038/s41579-025-01201-x.
3
Coupling optimization of cell growth cycle and key enzyme membrane localization for enhanced synthesis of high molecular weight heparosan by Corynebacterium glutamicum.
Bioresour Bioprocess. 2025 Jun 17;12(1):61. doi: 10.1186/s40643-025-00899-0.
4
Synthesis and anti-mycobacterial activity of novel medium-chain β-lactone derivatives: a multi-target strategy to combat .
RSC Med Chem. 2025 Apr 25. doi: 10.1039/d5md00102a.
5
Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE.
Nat Commun. 2025 Apr 29;16(1):3974. doi: 10.1038/s41467-025-57843-1.
6
Drug resistant Mycobacterium tuberculosis strains have altered cell envelope hydrophobicity that influences infection outcomes in human macrophages.
Sci Rep. 2024 Dec 28;14(1):30840. doi: 10.1038/s41598-024-81457-0.
7
Decoding the role of mycobacterial lipid remodelling and membrane dynamics in antibiotic tolerance.
Chem Sci. 2024 Oct 29;15(45):19084-93. doi: 10.1039/d4sc06618a.
8
Structures of the Mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition.
Nat Commun. 2024 Sep 4;15(1):7710. doi: 10.1038/s41467-024-51948-9.
9
Terrabacteria: redefining bacterial envelope diversity, biogenesis and evolution.
Nat Rev Microbiol. 2025 Jan;23(1):41-56. doi: 10.1038/s41579-024-01088-0. Epub 2024 Aug 28.
10
Identification of 2-(-aryl-1,2,3-triazol-4-yl) quinoline derivatives as antitubercular agents endowed with InhA inhibitory activity.
Front Chem. 2024 Aug 7;12:1424017. doi: 10.3389/fchem.2024.1424017. eCollection 2024.
本文引用的文献
1
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.
Microbiol Spectr. 2014 Aug;2(4):MGM2-0021-2013. doi: 10.1128/microbiolspec.MGM2-0021-2013.
2
New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
Curr Pharm Des. 2014;20(27):4357-78. doi: 10.2174/1381612819666131118203641.
3
Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen.
Nat Commun. 2013;4:2748. doi: 10.1038/ncomms3748.
4
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis.
PLoS One. 2013 Sep 23;8(9):e75245. doi: 10.1371/journal.pone.0075245. eCollection 2013.
5
Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactions.
Cell Microbiol. 2014 Feb;16(2):195-213. doi: 10.1111/cmi.12214. Epub 2013 Oct 16.
6
Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45.
J Biol Chem. 2013 Oct 18;288(42):30309-30319. doi: 10.1074/jbc.M113.492173. Epub 2013 Aug 28.
7
Isotuberculosinol: the unusual case of an immunomodulatory diterpenoid from .
Medchemcomm. 2012 Aug 1;3(8):899-904. doi: 10.1039/c2md20030a.
8
Immunomodulation of alveolar epithelial cells by Mycobacterium tuberculosis phosphatidylinositol mannosides results in apoptosis.
APMIS. 2014 Apr;122(4):268-82. doi: 10.1111/apm.12141. Epub 2013 Aug 6.
9
Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.
Future Microbiol. 2013 Jul;8(7):855-75. doi: 10.2217/fmb.13.52.
10
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32.
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11565-70. doi: 10.1073/pnas.1302114110. Epub 2013 Jun 24.
Zotero 插件